recent studies have suggested that patients with prolactinomas have a defect in the central regulation of prolactin ( prl ) release but it is not clear whether the defect results from a true loss of hypothalamic dopamine activity or from a functional inability of inherent dopaminergic inhibition to be mediated effectively .
C0013030
dopamine
C0282151
dopaminergic